Home > Publications Database > Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia. > print

001     137652
005     20240321220304.0
024 7 _ |a 10.1212/WNL.0000000000000865
|2 doi
024 7 _ |a pmid:25194012
|2 pmid
024 7 _ |a 0028-3878
|2 ISSN
024 7 _ |a 1526-632X
|2 ISSN
024 7 _ |a altmetric:2662328
|2 altmetric
037 _ _ |a DZNE-2020-03974
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Prüss, Harald
|0 P:(DE-2719)2810931
|b 0
|e First author
|u dzne
245 _ _ |a Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia.
260 _ _ |a [S.l.]
|c 2014
|b Ovid
264 _ 1 |3 online
|2 Crossref
|b Ovid Technologies (Wolters Kluwer Health)
|c 2014-09-05
264 _ 1 |3 print
|2 Crossref
|b Ovid Technologies (Wolters Kluwer Health)
|c 2014-10-07
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1594206632_24854
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Autoantibodies
|2 NLM Chemicals
650 _ 7 |a GRM5 protein, human
|2 NLM Chemicals
650 _ 7 |a Immunoglobulin G
|2 NLM Chemicals
650 _ 7 |a Receptor, Metabotropic Glutamate 5
|2 NLM Chemicals
650 _ 7 |a Methylprednisolone
|0 X4W7ZR7023
|2 NLM Chemicals
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Autoantibodies: blood
|2 MeSH
650 _ 2 |a Autoantibodies: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Immunoglobulin G: blood
|2 MeSH
650 _ 2 |a Immunoglobulin G: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Limbic Encephalitis: blood
|2 MeSH
650 _ 2 |a Limbic Encephalitis: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Limbic Encephalitis: complications
|2 MeSH
650 _ 2 |a Limbic Encephalitis: drug therapy
|2 MeSH
650 _ 2 |a Limbic Encephalitis: immunology
|2 MeSH
650 _ 2 |a Limbic Encephalitis: therapy
|2 MeSH
650 _ 2 |a Methylprednisolone: therapeutic use
|2 MeSH
650 _ 2 |a Plasma Exchange
|2 MeSH
650 _ 2 |a Prosopagnosia: blood
|2 MeSH
650 _ 2 |a Prosopagnosia: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Prosopagnosia: complications
|2 MeSH
650 _ 2 |a Prosopagnosia: drug therapy
|2 MeSH
650 _ 2 |a Prosopagnosia: immunology
|2 MeSH
650 _ 2 |a Prosopagnosia: therapy
|2 MeSH
650 _ 2 |a Receptor, Metabotropic Glutamate 5: drug effects
|2 MeSH
650 _ 2 |a Receptor, Metabotropic Glutamate 5: immunology
|2 MeSH
700 1 _ |a Rothkirch, Marcus
|b 1
700 1 _ |a Kopp, Ute
|b 2
700 1 _ |a Hamer, Hajo M
|b 3
700 1 _ |a Hagge, Mareike
|b 4
700 1 _ |a Sterzer, Phillipp
|b 5
700 1 _ |a Saschenbrecker, Sandra
|b 6
700 1 _ |a Stöcker, Winfried
|b 7
700 1 _ |a Harms, Lutz
|b 8
700 1 _ |a Endres, Matthias
|0 P:(DE-2719)2811033
|b 9
|e Last author
|u dzne
773 1 8 |a 10.1212/wnl.0000000000000865
|b : Ovid Technologies (Wolters Kluwer Health), 2014-09-05
|n 15
|p 1384-1386
|3 journal-article
|2 Crossref
|t Neurology
|v 83
|y 2014
|x 0028-3878
773 _ _ |a 10.1212/WNL.0000000000000865
|g Vol. 83, no. 15, p. 1384 - 1386
|0 PERI:(DE-600)1491874-2
|n 15
|q 83:15<1384 - 1386
|p 1384-1386
|t Neurology
|v 83
|y 2014
|x 0028-3878
909 C O |o oai:pub.dzne.de:137652
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2810931
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2811033
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2014
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROLOGY : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEUROLOGY : 2017
920 1 _ |0 I:(DE-2719)1810003
|k AG Prüß
|l Autoimmune Enzephalopathies
|x 0
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Coordinator of Clinical Research
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1810003
980 _ _ |a I:(DE-2719)1811005
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21